OrbiMed Advisors LLC

SEC CIK: 0001055951
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

DRUG holding history

Bright Minds Biosciences Inc. in every 13F filed by OrbiMed Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DRUG overview All 13F holders of DRUG Full Q2 2026 holdings

Shares (Q2 2026): 93,000
Value: $6.53M
% of portfolio: 0.1%
Quarters held: 3; Since Q4 2021

Holdings of DRUG by OrbiMed Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	93,000	$6.53M	0.1%	+53,000+132.5%	Added	Holders
Q1 2026	40,000	$2.92M	0.1%	+40,000	New	Holders
Q1 2022	0	$0	0.0%	−660,600−100.0%	Sold out	Holders
Q4 2021	660,600	$2.13M	<0.1%	+660,600	New	Holders